MediPen Ltd, Vision Court, Caxton Place,
Cardiff, Wales, CF23 8HA, United Kingdom
- Phytocannabinoid Combination Therapy
- ECS Interactions Within Zebrafish Models
- Non-Psychotropic Cannabinoids In Oncology
We are committed to carrying out groundbreaking research and developing an array of licensed cannabinoid medicines. With our state-of-the-art dedicated research facility we aim to propel the UK to the forefront of global cannabis research and develop a unique portfolio of cannabinoid based treatments focusing on combating aggressive oncological disorders.
Our current research programme looks at the effects of non-psychotropic cannabinoid combinations on malignant tumour cells located in the primary organs of the respiratory system. The data from this research will be utilised to further the process of bringing our first treatment to the market.
We've invested over £1.4m to date developing our custom built 1800sq² ft facility located within the heart of Cardiff, Wales. With the launch of our groundbreaking research programme we will utilise cutting edge equipment to conduct much needed research into the oncological effects of non-psychotropic cannabinoid combinations.
With dedication, passion and smart planning we constantly strive to achieve our goals as quickly as possible. From building robust infrastructure to assembling strong teams and obtaining cumulative data through carrying out important research, we consistently achieve the unachievable within exceedingly concise timescales.
To find our more information please feel free to get in touch
with us at any time.